LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
BT-20 XMD16-144
1.11
uM
LJP5
2
M09
72
hr
1097 1392 3877 0.3590 0.1396
BT-20 XMD16-144
1.11
uM
LJP5
3
M09
72
hr
1097 1347 3925 0.3432 0.1180
BT-20 XMD16-144
3.33
uM
LJP5
1
M08
72
hr
1097 1344 3735 0.3598 0.1216
BT-20 XMD16-144
3.33
uM
LJP5
2
M08
72
hr
1097 1315 3877 0.3391 0.1045
BT-20 XMD16-144
3.33
uM
LJP5
3
M08
72
hr
1097 1277 3925 0.3253 0.0860
BT-20 XMD16-144
10
uM
LJP5
1
M07
72
hr
1097 1015 3735 0.2717 -0.0431
BT-20 XMD16-144
10
uM
LJP5
2
M07
72
hr
1097 1168 3877 0.3012 0.0349
BT-20 XMD16-144
10
uM
LJP5
3
M07
72
hr
1097 971 3925 0.2474 -0.0643
BT-20 Erlotinib
0.04
uM
LJP5
1
M24
72
hr
1097 3122 3735 0.8358 0.8070
BT-20 Erlotinib
0.04
uM
LJP5
2
M24
72
hr
1097 3202 3877 0.8257 0.8004
BT-20 Erlotinib
0.04
uM
LJP5
3
M24
72
hr
1097 3808 3925 0.9701 0.9672
BT-20 Erlotinib
0.12
uM
LJP5
1
M23
72
hr
1097 3137 3735 0.8398 0.8119
BT-20 Erlotinib
0.12
uM
LJP5
2
M23
72
hr
1097 3267 3877 0.8425 0.8204
BT-20 Erlotinib
0.12
uM
LJP5
3
M23
72
hr
1097 3439 3925 0.8761 0.8612
BT-20 Erlotinib
0.37
uM
LJP5
1
M22
72
hr
1097 3178 3735 0.8508 0.8253
BT-20 Erlotinib
0.37
uM
LJP5
2
M22
72
hr
1097 3320 3877 0.8562 0.8365
BT-20 Erlotinib
0.37
uM
LJP5
3
M22
72
hr
1097 3490 3925 0.8891 0.8761
BT-20 Erlotinib
1.11
uM
LJP5
1
M21
72
hr
1097 3381 3735 0.9052 0.8904
BT-20 Erlotinib
1.11
uM
LJP5
2
M21
72
hr
1097 3027 3877 0.7806 0.7457
BT-20 Erlotinib
1.11
uM
LJP5
3
M21
72
hr
1097 3089 3925 0.7869 0.7557
BT-20 Erlotinib
3.33
uM
LJP5
1
M20
72
hr
1097 3165 3735 0.8473 0.8211
BT-20 Erlotinib
3.33
uM
LJP5
2
M20
72
hr
1097 3451 3877 0.8899 0.8760
BT-20 Erlotinib
3.33
uM
LJP5
3
M20
72
hr
1097 3079 3925 0.7844 0.7526
BT-20 Erlotinib
10
uM
LJP5
1
M19
72
hr
1097 2638 3735 0.7063 0.6427
BT-20 Erlotinib
10
uM
LJP5
2
M19
72
hr
1097 2710 3877 0.6989 0.6428